A New Parameter Derived From DSA to Evaluate Cerebral Perfusion — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A New Parameter Derived From DSA to Evaluate Cerebral Perfusion — Stella

Recruiting

Back to Cerebral Ischemia trials

Trial locations(1 site)

China

Xi'an No.3 Hospital, Xi'an, Shaanxi

Key details

Sponsor

Xi'an No.3 Hospital

Enrollment target

~30,000 participants

Started

July 2018

Primary completion

July 2028

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov